New device aims to improve survival in aortic arch surgery

NCT ID NCT07089576

Recruiting now Disease control Sponsor: Artivion Inc. Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jul 10, 2026 · Updated 2 times

Summary

This study tests a new device called the Arcevo LSA Hybrid Stent Graft, used during open surgery to repair the aortic arch in people with aneurysms or dissections. The device is implanted to support the aorta and its left subclavian artery branch. Researchers will track safety and effectiveness in 132 participants over time, watching for serious events like stroke, paralysis, or death.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Arcevo LSA Hybrid Stent Graft System (a device implanted during open surgery to repair the aortic arch)
What this could lead to: If successful, this device could provide a safer, more effective way to repair life-threatening aortic arch aneurysms and dissections during open surgery.
What could go wrong: This is an early-stage study with only 132 participants, so results may not apply to everyone. Risks include stroke, paralysis, or need for additional surgery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Aneurysm, Aortic Arch Dissection, Thoracic Aorta thoracic aortic aneurysm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE AORTIC DISSECTION AORTIC ARCH ANEURYSM AORTIC ARCH DISSECTION CHRONIC AORTIC DISSECTION

Contacts and locations

Locations

Allegheny General Hospital
RECRUITING

Pittsburgh, Pennsylvania, 15212, United States
Baylor Scott & White
RECRUITING

Plano, Texas, 75093, United States
Cleveland Clinic Foundation
RECRUITING

Cleveland, Ohio, 44195, United States
Columbia University Irving Medical Center/New York Presbyterian Hospital
RECRUITING

New York, New York, 10032, United States
Cornell Medical College (Presbyterian Weill)
RECRUITING

New York, New York, 10065, United States
Emory University School of Medicine
RECRUITING

Atlanta, Georgia, 30322, United States
Jefferson Health
RECRUITING

Philadelphia, Pennsylvania, 19107, United States
Johns Hopkins Hospital
RECRUITING

Baltimore, Maryland, 21287, United States
MedStar Washington Health
RECRUITING

Washington D.C., District of Columbia, 20010, United States
Medical College of Wisconsin
RECRUITING

Milwaukee, Wisconsin, 53226, United States
Montefiore Medical Center
RECRUITING

The Bronx, New York, 10467, United States
Northwell Health
RECRUITING

New York, New York, 10075, United States
Northwestern University Feinberg School of Medicine
RECRUITING

Chicago, Illinois, 60611, United States
University of Alabama
RECRUITING

Birmingham, Alabama, 35205, United States
University of Colorado Hospital
RECRUITING

Aurora, Colorado, 80045, United States
University of Florida-Shands
RECRUITING

Gainesville, Florida, 32608, United States
University of Michigan
RECRUITING

Ann Arbor, Michigan, 48109, United States
University of Southern California
RECRUITING

Los Angeles, California, 90033, United States
University of Texas - Austin
RECRUITING

Austin, Texas, 78705, United States
University of Texas, McGovern Medical Center
RECRUITING

Houston, Texas, 77030, United States
University of Washington / Harborview Medical Center
RECRUITING

Seattle, Washington, 98105, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.